Share this post:
Adult stem cells may have the ability to improve and possibly even reverse the effects of type 1 diabetes mellitus, a chronic illness characterized by the body’s inability to produce insulin. About 1.25 million Americans have type 1 diabetes, and an estimated 40,000 people will be newly diagnosed each year in the U.S., according to the American Diabetes Association.
Known as juvenile diabetes, type 1 diabetes is usually diagnosed in children and young adults, but the disease can also develop in adults in their late 30s and early 40s. Only 5% of people with diabetes have this form of the disease.
Type 1 diabetes occurs when the body stops producing insulin due to the autoimmune destruction of the beta cells in the pancreas. The body breaks down the sugars and starches into glucose that it uses for energy, but it needs insulin to get glucose from the bloodstream into the cells.
Typically, patients with type 1 diabetes require lifelong insulin therapy. In combination with a healthy lifestyle and nutrition, regenerative medicine and stem cell therapy may provide individuals with the ability to decrease and possibly eliminate their insulin use. Stem cell therapy may also have the potential to repair tissues and organs damaged as a result of diabetes mellitus.
Recent studies show that Mesenchymal Stem Cells (MSCs) may have the ability to improve and possibly even reverse the effects of diabetes mellitus. MSCs have the capacity to differentiate and migrate to the site of damage and secrete growth factors or cytokines. In type 1 diabetes, the insulin producing cells – beta cells within the pancreatic islets – are being destroyed by the immune system. According to recent publications, MSCs may help increase insulin secretion, raise the number of islet cells in the pancreas, enhance islet survival, and treat diabetic ulcers and limb ischemia.
MSCs efficiently differentiate into insulin-producing cells in the pancreatic islet microenvironment both in vitro and in vivo, according to a study published in The Journal of Cell Therapy. During the study, MSCs differentiated into insulin-producing cells after 38 days of co-culture, as confirmed by insulin and C-peptide staining. MSCs have also been shown to travel to the site of injury, the pancreatic islets and the liver, where they have the potential to contribute to tissue repair and remodeling, as well as improving metabolic function.
At U.S. Stem Cell Clinic, we utilize adult stem cells, which are found in every part of the body and can be harvested from a patient’s own tissue, such as adipose (fat) tissue, muscle, teeth, skin or bone marrow. During a simple and safe outpatient procedure, stem cells can easily be isolated from a patient’s tissue in approximately 30-90 minutes under local anesthesia. Often times, they can then be injected after the extraction immediately. The procedure is safe, ethical and legal, and offers minimal patient discomfort.
Our team has successfully treated over 7,000 patients with very few safety concerns reported. We are extremely encouraged by the positive patient results we are seeing from our physician-based treatments. Stem cells possess enormous regenerative potential. Our hope is that stem cell therapy will provide relief and an improved quality of life for many patients.
To find out how stem cell therapy can help you improve your life, please request your free, no-obligation consultation on our website: https://usstemcellclinic.com/contact-us or by calling 954-510-3150.